Followers | 53 |
Posts | 3489 |
Boards Moderated | 0 |
Alias Born | 02/05/2014 |
Wednesday, April 15, 2015 7:45:10 PM
As soon as the volume of available 1's for sale runs low, the market makers pile another batch on the ask. Their objective is not to make a profit on the sale. They have already been paid a fee to handle this selloff. Their objective is simply to get retail buyers to continue to buy more shares.
The good news is that eventually the financiers will have sold enough shares to pay off DNA's debt. At that point, perhaps the financiers, or someone else, will provide DNA management with the funding required to bring their new product to market. Because Mel told another iHub poster last week that DNA still no funding for the new product, it is easy to see that funding availability for a new product has probably been restricted until DNA first clears their existing debt.
So, if you can afford to risk the loss, I encourage you all to buy more shares of DNAX. ; )
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM